The aggregation of a small peptide named amyloid β (Aβ) is associated with AD, and the inhibition of both cholinesterase sites (acetylcholinesterase, AChE, and butyrylcholinesterase, BChE) may prevent this aggregation [444]. Here, BCHE is linked to Alzheimer disease.